Table S2.
Δ weight (%m) vs. Sox9 | Δ weight (%m) vs. Comp | Δ weight (%m) vs. Mmp3 | Δ weight (%m) vs. Mmp9 | Δ weight (%m) vs. Mmp13 | Δ weight (%m) vs. Timp1 | ||
---|---|---|---|---|---|---|---|
weight (%m) vs gene expression | r | 0.05944 | −0.04753 | −0.09938 | −0.09954 | 0.4122 | 0.2161 |
95% confidence interval | −0.8685 to 0.8949 | −0.8924 to 0.8714 | −0.9026 to 0.8582 | −0.9026 to 0.8582 | −0.7389 to 0.9493 | −0.8232 to 0.9225 | |
R square | 0.003533 | 0.002259 | 0.009877 | 0.009908 | 0.1699 | 0.04668 | |
P (one-tailed) | 0.4622 | 0.4698 | 0.4368 | 0.4367 | 0.2452 | 0.3635 | |
p-value summary | ns | ns | ns | ns | ns | ns | |
Significant? (α = 0.05) | No | No | No | No | No | No | |
Number of XY pairs | 5 | 5 | 5 | 5 | 5 | 5 | |
| |||||||
Δ weight (%m) vs. Cnr1 | Δ weight (%m) vs. Cnr2 | Δ weight (%m) vs. Faah | Δ weight (%m) vs. Napepld | Δ weight (%m) vs. Alox15 | Δ weight (%m) vs. Ptsg2 | ||
| |||||||
r | −0.5224 | −0.03812 | −0.1887 | 0.005075 | 0.3837 | 0.3332 | |
95% confidence interval | −0.9615 to 0.6677 | −0.8905 to 0.8736 | −0.9182 to 0.8322 | −0.8812 to 0.8835 | −0.7539 to 0.9458 | −0.7778 to 0.9394 | |
R square | 0.2729 | 0.001453 | 0.03561 | 2.58E-05 | 0.1472 | 0.111 | |
P (one-tailed) | 0.1832 | 0.4757 | 0.3806 | 0.4968 | 0.2619 | 0.2919 | |
p-value summary | ns | ns | ns | ns | ns | ns | |
Significant? (α = 0.05) | No | No | No | No | No | No | |
Number of XY pairs | 5 | 5 | 5 | 5 | 5 | 5 | |
| |||||||
weight (%m) vs gene expression | Δ weight (%m) vs. Timp2 | Δ weight (%m) vs. Gde1 | Δ weight (%m) vs. Plcb1 | Δ weight (%m) vs. Alox12 | Δ weight (%m) vs. Pla2g2a | Δ weight (%m) vs. TIMP1 | |
| |||||||
r | 0.04022 | 0.5007 | 0.3764 | 0.399 | 0.2813 | 0.2321 | |
95% confidence interval | −0.8731 to 0.8909 | −0.6837 to 0.9593 | −0.7575 to 0.9449 | −0.7460 to 0.9477 | −0.7995 to 0.9322 | −0.8177 to 0.9250 | |
R square | 0.001618 | 0.2507 | 0.1417 | 0.1592 | 0.07911 | 0.05387 | |
P (one-tailed) | 0.4744 | 0.1951 | 0.2662 | 0.2529 | 0.3233 | 0.3536 | |
p-value summary | ns | ns | ns | ns | ns | ns | |
Significant? (α = 0.05) | No | No | No | No | No | No | |
Number of XY pairs | 5 | 5 | 5 | 5 | 5 | 5 | |
| |||||||
Δ weight (%m) vs. SOX9 | Δ weight (%m) vs. COMP | Δ weight (%m) vs. MMP3 | Δ weight (%m) vs. MMP2 | Δ weight (%m) vs. MMP9 | Δ weight (%m) vs. MMP13 | ||
| |||||||
r | 0.5237 | 0.6089 | 0.07722 | 0.9253 | −0.4425 | 0.3316 | |
95% confidence interval | −0.6667 to 0.9617 | −0.5909 to 0.9701 | −0.8640 to 0.8984 | 0.2340 to 0.9952 | −0.9528 to 0.7216 | −0.7785 to 0.9392 | |
R square | 0.2743 | 0.3707 | 0.005963 | 0.8562 | 0.1958 | 0.11 | |
P (one-tailed) | 0.1825 | 0.1379 | 0.4509 | 0.0121 | 0.2278 | 0.2928 | |
p-value summary | ns | ns | ns | * | ns | ns | |
Significant? (α = 0.05) | No | No | No | Yes | No | No | |
Number of XY pairs | 5 | 5 | 5 | 5 | 5 | 5 | |
| |||||||
Δ weight (%m) vs. CB1 | Δ weight (%m) vs. CB2 | Δ weight (%m) vs. FAAH | Δ weight (%m) vs. NAPE- PLD | Δ weight (%m) vs. 15LOX2 | Δ weight (%m) vs. COX2 | ||
| |||||||
r | 0.8844 | 0.5222 | 0.8038 | −0.8895 | 0.364 | 0.7891 | |
95% confidence interval | 0.009190 to 0.9924 | −0.6679 to 0.9615 | −0.2701 to 0.9865 | −0.9927 to -0.03346 | −0.7636 to 0.9434 | −0.3071 to 0.9854 | |
R square | 0.7821 | 0.2726 | 0.6461 | 7.91E-01 | 0.1325 | 0.6226 | |
P (one-tailed) | 0.0232 | 0.1834 | 0.0506 | 0.0217 | 0.2735 | 0.0563 | |
p-value summary | * | ns | ns | * | ns | ns | |
Significant? (alpha = 0.05) | Yes | No | No | Yes | No | No | |
Number of XY Pairs | 5 | 5 | 5 | 5 | 5 | 5 |
Notes: Correlation matrix for DWB data and expression levels. Pearson correlation analysis has been performed: 1) between behavioral effects and alterations in gene expression levels, and 2) between behavioral effects and alterations in protein expression levels (grey shading); p<0.05 has been considered significant.
Abbreviations: COMP, cartilage oligomeric matrix protein; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of metalloproteinase; FAAH, fatty acid amide hydrolase; NAPE-PLD, N-acyl phosphatidylethanolamine phospholipase D.